Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ventricular Assist Device Trials Need Redesign, FDA And Advisers Agree

This article was originally published in The Gray Sheet

Executive Summary

FDA agrees with its advisory panel that it should work with industry to develop better trial designs for left ventricular assist devices

You may also be interested in...



NIH Group Proposes Ventricular Assist Study For “Less Sick” Patients

The National Heart Lung and Blood Institute and an interdisciplinary team of experts is trying to develop a multi-device clinical trial to test the benefits of ventricular assist devices in patients with advanced, but not end-stage, heart failure

NIH Group Proposes Ventricular Assist Study For “Less Sick” Patients

The National Heart Lung and Blood Institute and an interdisciplinary team of experts is trying to develop a multi-device clinical trial to test the benefits of ventricular assist devices in patients with advanced, but not end-stage, heart failure

Advisory Panel Votes 12-0 In Favor Of Thoratec’s HeartMate II LVAD

FDA's Circulatory System Devices panel unanimously endorsed Thoratec's PMA for its HeartMate II implantable left ventricular assist device at its Nov. 30 meeting in Gaithersburg, Md

Related Content

UsernamePublicRestriction

Register

MT025585

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel